VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $103,000 | +139.5% | 5,991 | +189.4% | 0.00% | – |
| Q4 2017 | $43,000 | +104.8% | 2,070 | +39.6% | 0.00% | – |
| Q3 2017 | $21,000 | -79.0% | 1,483 | -74.2% | 0.00% | – |
| Q2 2017 | $100,000 | +96.1% | 5,744 | +27.6% | 0.00% | – |
| Q1 2017 | $51,000 | -12.1% | 4,500 | +10.7% | 0.00% | – |
| Q4 2016 | $58,000 | -64.8% | 4,064 | -39.4% | 0.00% | -100.0% |
| Q3 2016 | $165,000 | -10.3% | 6,709 | -26.4% | 0.00% | 0.0% |
| Q2 2016 | $184,000 | -30.3% | 9,120 | -9.3% | 0.00% | 0.0% |
| Q1 2016 | $264,000 | -57.4% | 10,056 | +65.2% | 0.00% | -66.7% |
| Q4 2015 | $619,000 | -79.8% | 6,088 | -64.5% | 0.00% | -80.0% |
| Q3 2015 | $3,063,000 | -22.2% | 17,170 | -3.1% | 0.02% | -21.1% |
| Q2 2015 | $3,938,000 | +4.9% | 17,727 | -6.2% | 0.02% | 0.0% |
| Q1 2015 | $3,754,000 | +345.8% | 18,901 | +221.2% | 0.02% | +111.1% |
| Q4 2014 | $842,000 | +100.0% | 5,885 | +83.4% | 0.01% | +125.0% |
| Q3 2014 | $421,000 | +23.8% | 3,208 | +18.9% | 0.00% | 0.0% |
| Q2 2014 | $340,000 | -1.7% | 2,697 | +2.6% | 0.00% | 0.0% |
| Q1 2014 | $346,000 | -19.7% | 2,628 | -28.4% | 0.00% | -20.0% |
| Q4 2013 | $431,000 | +27.5% | 3,668 | +13.3% | 0.01% | +25.0% |
| Q3 2013 | $338,000 | +1.5% | 3,238 | -16.4% | 0.00% | 0.0% |
| Q2 2013 | $333,000 | – | 3,873 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |